Ali Nihat Annakkaya

Ali Nihat Annakkaya

Auto-generated profile, based on publicly available information

Ali Nihat Annakkaya

Düzce University

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Tumori Journal
Verified
Journal Article
Closed access
AAAli Nihat Annakkaya
Ali Nihat Annakkaya
PAPeri Arbak
Peri Arbak
OBOner Balbay
Oner Balbay
CBCahit Bilgin
Cahit Bilgin
MEMete Erbas
Mete Erbas
IBIsmet Bulut
Ismet Bulut
Aims and background: To evaluate the relationship between delayed diagnosis and the degree of invasion and survival in lung cancer. Methods: One hundred and three patients (96 men) with lung cancer were included. Stages in the diagnosis of lung cancer were classified as follows: symptom-to-doctor interval, i.e., the interval from the first symptoms related to the presence of lung cancer to the first consultation with a medical professional; doctor-to-diagnosis interval, i.e., the interval between the first medical visit and confirmation of the diagnosis; and diagnosis-to-treatment interval, i.e., the interval between diagnosis and complete TNM staging and treatment. The symptom-to-treatment interval (STI) was the sum of the 3 intervals. The degree of invasion was determined by the TNM classification. Results: The patients were followed up for a mean period (± SD) of 7.4 ± 8.7 months. Seventy-six (74%) patients were diagnosed with non-small cell lung cancer (NSCLC) and 27 patients (26%) with small cell lung cancer (SCLC). The mean length of STI was 120 ± 101 days (median, 90). The mean length of the symptom-to-doctor interval was 63 ± 62 days (median, 45), while the doctor-to-diagnosis and diagnosis-to-treatment intervals were 41 ± 82 days (median, 10) and 16 ± 12 days (median, 12), respectively. When the STIs of the patients were correlated with tumor stage, tumor invasion, lymph node involvement and metastasis, no significant differences were found. Patients with an STI longer than 60 days had a significantly longer survival. Regarding the type of lung cancer and STI, the median survival was shorter in patients with an STI of less than 60 days both in NSCLC and SCLC, although this was not statistically significant in SCLC. Conclusions: The shorter the diagnostic interval, the shorter was the median survival in our study. The reason for the apparent discrepancy between poor prognosis of lung cancer patients in spite of early diagnosis might be much faster progression of the disease itself.

22 August 2019 in The Aging Male
Verified
Journal Article
Closed access
YBYagmur Bahar
Yagmur Bahar
AAAli Nihat Annakkaya
Ali Nihat Annakkaya
CSCigdem Sen
Cigdem Sen
MOMehtap Oktay
Mehtap Oktay
FAFuat Aytekin
Fuat Aytekin
OBOner Balbay
Oner Balbay
The present study aimed to investigate the frequency of deep venous thrombosis (DVT) among patients with obstructive sleep apnea syndrome (OSAS). Patients who referred the preliminary diagnosis of OSAS were included in this study. D-dimer levels of all patients were measured, and D-dimer (+) patients were evaluated by Doppler USG of the lower-extremity. Mean age of the patient group was 52 ± 12 years and 31.8% (76/239) were women. The rate of D-dimer positivity among severe-OSAS cases (15/85) was significantly higher compared to the rest (13/154) (17.6% and 8.4%, respectively; p = 0.034). The risk of D-dimer positivity was elevated by 2.3 folds in severe-OSAS cases (OR: 2,324, 95% confidence interval: 1.048–5.152). Among 28 D-dimer (+) cases, 4 (14.2%) had DVT as demonstrated by USI of the lower-extremity. All four cases with DVT had severe OSAS. D-dimer was positive in 17.6% (15/85) of all severe OSAS cases. DVT was diagnosed in 4.7% (4/85) of severe-OSAS cases. DVT frequency was 26.6% (4/15) in D-dimer (+) severe-OSAS. Findings of this study indicate that severe-OSAS can be a significant risk factor for DVT. Additionally, data obtained in this study underline the benefits of questioning severe-OSAS patients with respect to DVT symptoms, investigating D-dimer levels and evaluating D-dimer (+) severe-OSAS cases for DVT prophylaxis.

18 December 2024 in Sleep Medicine
Verified
Journal Article
Open access
APAylin Pihtili
Aylin Pihtili
EKEsen Kiyan
Esen Kiyan
BBBaran Balcan
Baran Balcan
SASEMIH ARBATLI
SEMIH ARBATLI
ACAykut Cilli
Aykut Cilli
MAMuhammed Emin Akkoyunlu
Muhammed Emin Akkoyunlu
Previous reports from relatively small clinical cohorts have suggested that the clinical presentation of obstructive sleep apnea (OSA) differs between men and women. We aimed to explore sex differences in clinical and polysomnographic features of OSA in a large nationwide registry. Participants from the ongoing Turkish Sleep Apnea Database (TURKAPNE) Study from 34 centers were included in the current analysis. OSA was defined as an apnea-hypopnea index (AHI) ≥5 events/hour and was classified as mild, moderate, and severe according to AHI cut-offs 5, 15, and 30 events/hour, respectively. In all, 7130 patients (2259 women) were included. OSA was observed in 6323 (88.7 %), of whom 70.2 % were male and 29.8 % were female. In the OSA group, women were older (56.7 ± 11.9 vs. 49.5 ± 11.3 years; p < 0.001) and more obese (body mass index 34.3 ± 7.2 vs. 31.4 ± 5.6 kg/m2; p < 0.001) and had lower AHI (29.8 ± 24.1 vs. 36.8 ± 26.2 events/h; p < 0.001) than men. Loud snoring and witnessed apnea were more common in men than in women whereas women were more frequently presented with insomnia, headache, and mood changes. Women had significantly less total sleep time, less sleep efficiency, and longer sleep latency compared with men (p < 0.001 for each). Additionally, comorbid diseases such as diabetes mellitus, hypertension, asthma, psychiatric disorders, hypothyroidism as well as drug use were more common in women than in men independent of age and obesity (p < 0.05 for each). Our results suggest significant sex differences in clinical and polysomnographic features in this nationwide Turkish adult population. Women with OSA have more symptom burden and comorbidities despite having a less severe AHI.

20 July 2022 in American Journal of Infection Control
Verified
Journal Article
Closed access
PGpınar yıldız gülhan
pınar yıldız gülhan
PAPeri M. Arbak
Peri M. Arbak
AAAli N. Annakkaya
Ali N. Annakkaya
EBEge G. Balbay
Ege G. Balbay
ÖBÖner A. Balbay
Öner A. Balbay

1 February 2006 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
PDF file
BEBesir Erdogmus
Besir Erdogmus
BYBurhan Yazici
Burhan Yazici
OBOner Balbay
Oner Balbay
AAAli Nihat Annakkaya
Ali Nihat Annakkaya
BOBetul Ayca Ozdere
Betul Ayca Ozdere
IBIsmet Bulut
Ismet Bulut

15 February 2014
Verified
Journal Article
Closed access
IOIsmet Ozaydin
Ismet Ozaydin
AAAli Nihat Annakkaya
Ali Nihat Annakkaya
COCigdem Ozaydin
Cigdem Ozaydin
MAMetin Aydın
Metin Aydın